TY  - GEN
AU  - Pardanani,A
AU  - Gotlib,J
AU  - Roberts,A W
AU  - Wadleigh,M
AU  - Sirhan,S
AU  - Kawashima,J
AU  - Maltzman,J A
AU  - Shao,L
AU  - Gupta,V
AU  - Tefferi,A
TI  - Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis
SN  - 1476-5551
PY  - 2019///0219
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Benzamides
KW  - therapeutic use
KW  - Female
KW  - Humans
KW  - Janus Kinase 1
KW  - antagonists & inhibitors
KW  - Janus Kinase 2
KW  - Male
KW  - Middle Aged
KW  - Primary Myelofibrosis
KW  - drug therapy
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - Thrombocytosis
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2017.330
ER  -